Jiangsu Zhengtai Pharmaceutical and Chemical Co., Ltd. was established in January 2004. It is located in the Binjiang Pharmaceutical Industrial Park of Qidong City, Jiangsu Province, which integrates into the Shanghai economic circle on the north bank of the Yangtze River estuary. The company has a registered capital of 30 million yuan and a total investment of 186 million yuan. It covers an area of 200 acres and employs 160 people, with 25% holding college degrees or above. Among them, 16 are quality management personnel, accounting for 10%.

The company integrates research and development, production, and sales, primarily producing cephalosporin pharmaceutical intermediates. Its main products include: 7-ANCA (ceftizoxime nucleus), cefotiam hydrochloride, hexamethyldisilazane, picolinic acid, cefmetazole acid, cefodizime acid, agmatine sulfate, and others.

The company places great emphasis on the construction of its R&D team, which is led by overseas Ph.D. holders and consists of graduate students, undergraduates, and technical personnel with extensive industrial experience. It has established strategic partnerships with multiple research institutions and universities to ensure the continuity and advancement of subsequent product development, as well as to guarantee the company's sustainable, healthy, and rapid growth.

The company always adheres to the principles of "honesty and trustworthiness, technological innovation, quality first, and mutual development" in serving its customers. Enhancing value through technology is our eternal pursuit.